{"prompt": "['Abbreviated Title: Ph II SGI110 in Peds & Adults', '93', 'Version Date: 07/22/2019', '16.', 'Haller F, Moskalev EA, Faucz FR, et al. Aberrant DNA hypermethylation of SDHC: a', 'novel mechanism of tumor development in Carney triad. Endocr Relat Cancer 2014;21:567-77.', '17.', 'Averbuch SD, Steakley CS, Young RC, et al. Malignant pheochromocytoma effective', 'treatment with a combination of cyclophosphamide, vincristine, and dacarbazine. Ann Intern', 'Med 1988;109:267-73.', '18.', 'Tanabe A, Naruse M, Nomura K, Tsuiki M, Tsumagari A, Ichihara A. Combination', 'chemotherapy with cyclophosphamide, vincristine, and dacarbazine in patients with malignant', 'pheochromocytoma and paraganglioma. Horm Cancer 2013;4:103-10.', '19.', 'Niemeijer ND, Alblas G, van Hulsteijn LT, Dekkers OM, Corssmit EP. Chemotherapy', 'with cyclophosphamide, vincristine and dacarbazine for malignant paraganglioma and', 'pheochromocytoma: systematic review and meta-analysis. Clin Endocrinol (Oxf) 2014;81:642-', '51.', '20.', 'Fishbein L. Pheochromocytoma and Paraganglioma: Genetics, Diagnosis, and Treatment.', 'Hematol Oncol Clin North Am 2016;30:135-50.', '21.', 'Yoshinaga K, Oriuchi N, Wakabayashi H, et al. Effects and safety of (1)(3)(1)I-', 'metaiodobenzylguanidine (MIBG) radiotherapy in malignant neuroendocrine tumors: results', 'from a multicenter observational registry. Endocr J 2014;61:1171-80', '22.', 'Menko FH, Maher ER, Schmidt LS, et al. Hereditary leiomyomatosis and renal cell', 'cancer (HLRCC): renal cancerrisk surveillance and treatment. Fam Cancer 2014;13:637-44.', '23.', 'pharmaceuticals A. SGI-110 Investigator Brochure version number 5.0. 2014.', '24.', 'Network DTNCC.http://www.nccn.org/about/news/newsinfo.asp?News ID=47', '25.', 'Jacobsen PB, Donovan KA, Trask PC, et al. Screening for psychologic distress in', 'ambulatory cancer patients. Cancer 05;103:1494-502.', '26.', 'Ransom S, Jacobsen PB, Booth-Jones M. Validation of the Distress Thermometer with', 'bone marrow transplant patients. Psycho-oncology 2006; 15:604-12.', '27.', \"Zwahlen D, Hagenbuch N, Carley MI, Recklitis CJ, Buchi S. Screening cancer patients'\", 'families with the distress thermometer (DT): a validation study. Psycho-oncology 2008;17:959-', '66.', '28.', 'Patel SK, Mullins W, Turk A, Dekel N, Kinjo C, Sato JK. Distress screening, rater', 'agreement, and services in pediatric oncology. Psycho-oncology 2011;20:1324-33.', '29.', 'Wiener L ZS, Battles H, Pao M. Can an Adapted Distress Thermometer in the Pediatric', 'Population be Valid and Clinically Meaningful? Psycho-oncology 2012;21.', '30.', 'Cella D, Gershon R, Lai JS, Choi S. The future of outcomes measurement: item banking,', 'tailored short-forms, and computerized adaptive assessment. Quality of life research : an', 'international journal of quality of life aspects of treatment, care and rehabilitation 2007;16 Suppl', '1:133-41.', '31.', 'Cella D, Riley W, Stone A, et al. The Patient-Reported Outcomes Measurement', 'Information System (PROMIS) developed and tested its first wave of adult self-reported health', 'outcome item banks: 2005-2008. Journal of clinical epidemiology 2010;63:1179-94.']['Abbreviated Title: Ph II SGI110 in Peds & Adults', '94', 'Version Date: 07/22/2019', '32.', 'Varni JW, Stucky BD, Thissen D, et al. PROMIS Pediatric Pain Interference Scale: an', 'item response theory analysis of the pediatric pain item bank. The journal of pain : official', 'journal of the American Pain Society 2010;11:1109-19.', '33.', 'Miettinen M, Killian JK, Wang ZF, et al. Immunohistochemical loss of succinate', 'dehydrogenase subunit A (SDHA) in gastrointestinal stromal tumors (GISTs) signals SDHA', 'germline mutation. Am J Surg Pathol 2013;37:234-40.', '34.', 'Lai JP, Robbins PF, Raffeld M, et al. NY-ESO-1 expression in synovial sarcoma and', 'other mesenchymal tumors: significance for NY-ESO-1-based targeted therapy and differential', 'diagnosis. Mod Pathol 2012;25:854-8', '35.', 'Saxena N, Maio N, Crooks DR, et al. SDHB-Deficient Cancers: The Role of Mutations', 'That Impair Iron Sulfur Cluster Delivery. J Natl Cancer Inst 2015;10', '36.', 'Aspuria PJ, Lunt SY, Varemo L, et al. Succinate dehydrogenase inhibition leads to', 'epithelial-mesenchymal transition and reprogrammed carbon metabolism. Cancer Metab', '2014;2:21.', '37.', 'Lombardi G, Corona G, Bellu L, et al. Diagnostic value of plasma and urinary 2-', 'hydroxyglutarate to identify patients with isocitrate dehydrogenase-mutated glioma. Oncologist', '2015;20:562-7.', '38.', 'Liesenfeld DB, Botma A, Habermann N, et al. Aspirin Reduces Plasma Concentrations of', 'the Oncometabolite 2-Hydroxyglutarate: Results of a Randomized, Double-Blind, Crossover', 'Trial. Cancer Epidemiol Biomarkers Prev 2016;25:180-7.', '39.', 'Yang AS, Estecio MR, Doshi K, Kondo Y, Tajara EH, Issa JP. A simple method for', 'estimating global DNA methylation using bisulfite PCR of repetitive DNA elements. Nucleic', 'Acids Res 2004;32:e38.', '40.', 'Simon R. Optimal two-stage designs for phase II clinical trials. Control Clin Trials', '1989;10:1-10.']\n\n###\n\n", "completion": "END"}